Skip to main content
Home hosted by UNOPS Stop TB Partnership
  • Who We Are
    • Stop TB Partnership
      • Our Journey
      • Action Plan
    • The Secretariat
    • The Board
      • Board Members
      • Board Meetings
      • Board Committees
      • Board Delegations
      • Report of Decision Points
      • Board Affairs Documents
    • Stop TB Working Groups
  • What we do
    • Advocate to #EndTB
      • Tuberculosis Research Funding Trends, 2005–2020
      • Step Up for TB 2020
      • Governance of TB programs
      • Global Plan to End TB
      • World TB Day
      • UN High-Level Meeting on TB
      • Award Those Who Care
      • Advocacy and Communications
      • Hello Kitty
      • TB Talk Show
    • Prioritize people, human rights & gender
      • Fund TB communities & civil society
      • Community-Led Monitoring for Accountability
      • Promote Human Rights in TB
      • Support Gender Equality in TB
      • End TB Stigma
      • Reach Key & Vulnerable Populations
      • Empower TB Affected Communities & Civil Society
      • Strengthen national partnerships
      • Award those who care
    • Accelerate TB innovations
      • TB REACH
        • How TB REACH Works
        • The Team
        • TB REACH Impact
        • Catalyzing Diagnostic Use
        • Ground Up Innovation
        • Monitoring Success
        • Waves of funding
        • TB REACH Publications
      • Re-imagining TB care
        • “Sandbox” Network
        • Mapping the Technology Landscape of National TB Programs
        • Virtual Innovation Spotlights
      • Accelerator for Impact (a4i)
      • Digital Health Technology Hub
        • AI-Powered Computer-Aided Detection (CAD) Software
        • Community-Led Monitoring Tools
        • Diagnostics Connectivity Solutions
        • Digital Adherence Technologies
        • Global DAT Task Force
      • The Introducing New Tools Project
    • Facilitate Access to TB Drugs & Diagnostics
      • Global Drug Facility (GDF)
        • Mission
        • Market & Partner Coordination
        • Buyers
        • Suppliers
        • New Tools
        • Technical Assistance
        • Products Catalog
    • Provide technical support and capacity building
  • Partner With Us
    • Why Become a Partner
    • How to become a Partner
    • The benefits of partnership
    • Our Partners
    • Joining Forces to #EndTB
      • Additional resources
  • Resources
    • TB & COVID
    • Interactive TB data
      • Interactive Country Dashboard
      • Interactive Map Dashboard
      • Treatment Dashboard
    • UNHLM Targets & Commitments
    • GDF Resources
    • World TB Day
    • COMMUNITIES, RIGHTS AND GENDER
    • At A Glance
    • More ...
      • Publications
      • Reports
    • Digital TB Assessment
  • News
    • News
    • Events
    • Newsletter
  • Donate
  1. Home
  2. Considerations for selection of SARS-CoV-2 diagnostics and potential multiplexing: A perspective to ensure continuity of care for people with TB
  • Facebook logo
  • Twitter logo

Considerations for selection of SARS-CoV-2 diagnostics and potential multiplexing: A perspective to ensure continuity of care for people with TB

PDF icon Download Considerations%20for%20selection%20of%20SARS-CoV-2%20diagnostics.pdf (596.94 KB)

The Stop TB Partnership

Global Health Campus,
Chemin du Pommier 40,
1218 Le Grand-Saconnex, Geneva, Switzerland

Find us on Facebook Find us on Twitter Find us on Instagram Find us on LinkedIn

Useful links

  • Careers
  • Sitemap
  • FAQ
  • Terms of Use
  • Contact
  • Privacy Policy

Suscribe to stay informed

Sign up to learn more about TB and events.

© 2019 Stop TB Partnership - hosted by UNOPS
access